Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Joyce N. Barlin"'
Autor:
Joyce N. Barlin, Qin C. Zhou, Mario M. Leitao, Maria Bisogna, Narciso Olvera, Karin K. Shih, Anders Jacobsen, Nikolaus Schultz, William D. Tap, Martee L. Hensley, Gary K. Schwartz, Jeff Boyd, Li-Xuan Qin, Douglas A. Levine
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 17, Iss 2, Pp 183-189 (2015)
The molecular etiology of uterine leiomyosarcoma (ULMS) is poorly understood, which accounts for the wide disparity in outcomes among women with this disease. We examined and compared the molecular profiles of ULMS and normal myometrium (NL) to ident
Externí odkaz:
https://doaj.org/article/374091b1a94448208ed2e446f68586cf
Autor:
Bradley J. Monk, Christine Parkinson, Myong Cheol Lim, David M. O'Malley, Ana Oaknin, Michelle K. Wilson, Robert L. Coleman, Domenica Lorusso, Paul Bessette, Sharad Ghamande, Athina Christopoulou, Diane Provencher, Emily Prendergast, Fuat Demirkiran, Olga Mikheeva, Oladapo Yeku, Anita Chudecka-Glaz, Michael Schenker, Ramey D. Littell, Tamar Safra, Hung-Hsueh Chou, Mark A. Morgan, Vít Drochýtek, Joyce N. Barlin, Toon Van Gorp, Fred Ueland, Gabriel Lindahl, Charles Anderson, Dearbhaile C. Collins, Kathleen Moore, Frederik Marme, Shannon N. Westin, Iain A. McNeish, Danny Shih, Kevin K. Lin, Sandra Goble, Stephanie Hume, Keiichi Fujiwara, Rebecca S. Kristeleit
Publikováno v:
Scientia
PURPOSE ATHENA (ClinicalTrials.gov identifier: NCT03522246 ) was designed to evaluate rucaparib first-line maintenance treatment in a broad patient population, including those without BRCA1 or BRCA2 (BRCA) mutations or other evidence of homologous re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312a6e609ec98f3f3c5b48462663544d
https://hdl.handle.net/11351/8726
https://hdl.handle.net/11351/8726
Autor:
Thomas J Herzog, Kathleen Moore, Panagiotis A Konstantinopoulos, Lucy Gilbert, John L Hays, Bradley J Monk, David M O’Malley, Joyce N Barlin, Julie R Graham, Monali Desai, Yan Wang, Yangchun Du, Rita Dalal, Robert L Coleman, Jalid Sehouli
Publikováno v:
Ovarian cancer.
Autor:
Thomas J. Herzog, Kathleen N. Moore, Panagiotis A. Konstantinopoulos, Lucy Gilbert, John L. Hays, Bradley J. Monk, David M. O'Malley, Jalid Sehouli, Joyce N. Barlin, Julie R. Graham, Monali Desai, MD, Yan Wang, Yangchun Du, Rita P. Dalal, Robert L. Coleman
Publikováno v:
Journal of Clinical Oncology. 40:TPS5609-TPS5609
TPS5609 Background: ARTISTRY-7 will evaluate the novel engineered cytokine nemvaleukin alfa (nemvaleukin, ALKS 4230) in pts with gynecologic cancers. Epithelial ovarian cancer (OC) is the 7th most common cause of cancer mortality in women. OC is an a
Autor:
Angeles Alvarez Secord, Lisa Marie Barroilhet, Myong Cheol Lim, Sunil Gupta, Sonia Oosman, Jada Srinivas Rao, John O. Schorge, Joyce N. Barlin, Lucy Gilbert, Devansu Tewari, Michael Gold, Diane M. Provencher, Jung-Yun Lee, Kristin Leigh Bixel, Eduardo Yañez, Lukas Rob, David M. O'Malley
Publikováno v:
Journal of Clinical Oncology. 40:TPS5619-TPS5619
TPS5619 Background: Oregovomab, a murine IgGκ1 monoclonal antibody, has high affinity binding to tumor associated antigen CA125, thus, rendering the target antigen CA125 more immunogenic or “neoantigen-like” through altered and enhanced antigen
Autor:
Karin K. Shih, Li-Xuan Qin, Martee L. Hensley, Mario M. Leitao, Narciso Olvera, Qin C. Zhou, William D. Tap, Maria Bisogna, Douglas A. Levine, Nikolaus Schultz, Gary K. Schwartz, Joyce N. Barlin, Jeff Boyd, Anders Jacobsen
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 17, Iss 2, Pp 183-189 (2015)
Neoplasia (New York, N.Y.)
Neoplasia (New York, N.Y.)
The molecular etiology of uterine leiomyosarcoma (ULMS) is poorly understood, which accounts for the wide disparity in outcomes among women with this disease. We examined and compared the molecular profiles of ULMS and normal myometrium (NL) to ident
Autor:
Qin C. Zhou, Xavier Matias-Guiu, Megan Lutz, Martee L. Hensley, Mario M. Leitao, Alexia Iasonos, Robert A. Soslow, Caryn M. St. Clair, Nadeem R. Abu-Rustum, Joyce N. Barlin, Richard R. Barakat
Publikováno v:
Repositorio Abierto de la UdL
Universitad de Lleida
Universitad de Lleida
ObjectiveWe propose a new staging system for stage I endometrial cancer and compare its performance to the 1988 and 2009 International Federation of Gynecology and Obstetrics (FIGO) systems.MethodsWe analyzed patients with 1988 FIGO stage I endometri
Autor:
Richard R. Barakat, Robert A. Soslow, Kaled M. Alektiar, Qin Zhou, Caryn M. St. Clair, Nadeem R. Abu-Rustum, Joyce N. Barlin, Martee L. Hensley, Mario M. Leitao, Alexia Iasonos
Publikováno v:
Gynecologic Oncology. 130:452-456
Objective The objectives of the study are to evaluate which clinicopathologic factors influenced overall survival (OS) in endometrial carcinoma and to determine if the surgical effort to assess para-aortic (PA) lymph nodes (LNs) at initial staging su
Autor:
Petar Jelinic, Maria Bisogna, Richard R. Barakat, Joyce N. Barlin, Fanny Dao, Dennis S. Chi, Douglas A. Levine, Narciso Olvera, Faina Bogomolniy
Publikováno v:
Gynecologic Oncology. 128:512-517
Objectives High-grade serous ovarian cancer (HGSOC) mostly presents at an advanced stage and has a low overall survival rate. However, a subgroup of patients are seemingly cured after standard initial therapy. We hypothesize that the molecular profil
Autor:
Deborah DeLair, C. Kim, Yukio Sonoda, Dennis S. Chi, Joyce N. Barlin, Kaled M. Alektiar, Richard R. Barakat, Fady Khoury-Collado, Mario M. Leitao, Nadeem R. Abu-Rustum
Publikováno v:
Gynecologic Oncology. 125:531-535
Objective To determine the false-negative rate of a surgical sentinel lymph node (SLN) mapping algorithm that incorporates more than just removing SLNs in detecting metastatic endometrial cancer. Methods A prospective database of all patients who und